Open in interactive viewer → charts, metric popovers & call review

OFX: The Investment Phase Is Over, the Sale Process Is Open, and the Only Voice Left Is a Sell-Side Analyst

A $72M micro-cap tells investors the spending peak has passed — while quietly telling them the Equals exclusive has lapsed and other suitors are circling back
OFX.AX · Earnings Call · 2026-11-09

The awkward first act: a loss dressed as a turning point

OFX Group reported the first half of FY27 with net operating income of $89.2 million, down 15% on the prior corresponding period, underlying EBITDA of $4 million against $14.5 million a year earlier, an underlying loss after tax of $3.3 million and a statutory loss of $6.7 million. The CEO's framing is that the numbers are a lagging indicator of a completed cost actions programme, not a broken business: “This growth in revenue, coupled with the cost actions we have taken signal the end of the investment phase and point to a return to stronger profitability in the second half and beyond.” — John Malcolm, CEO · 2026-11-09 The qualifier that matters is in the second half of that same sentence in the pack: down 15% versus prior corresponding period, but only down 2.7% versus 2H26, with quarter-on-quarter revenue growth in each of the last two quarters. That is the entire bull case in one data point — a business that has stopped shrinking, guiding to 2% to 3% NOI growth in the second half off the first-half base, and $15 million of annualised cost reductions ($10 million landing in 2H27, the residual $5 million in FY28) against a full-year operating expense base now guided to $159–162 million. On a low base, that is mechanically a large EBITDA uplift. On any base, it is a company asking to be believed on a slope rather than a level.

The proof points that are actually real

Beneath the soft headline there is one genuinely new operating fact, and it is the one management keeps returning to. The share of corporate active clients holding more than one non-FX product has moved from 10.1% to 11.7%, with new clients adopting multiproduct at over 25%, and — critically — those multiproduct clients now generate roughly double the quarterly average revenue per client of FX-only clients, with a lapse rate around one-third as high. Management notes that half of that incremental ARPC is *more FX*, not cross-sell, which is the strongest argument that the wallet and card build is driving engagement rather than merely diversifying a flat revenue line. The second proof point is client wallet balances: just under $295 million, up roughly 390%, producing $5.6 million of interest revenue for the half, up nearly 50% year on year even through a rate-cutting cycle. Add non-FX revenue of $1.8 million (up roughly 290%, and clearing $1 million in a single quarter for the first time in Q2) and the new revenue streams annualise north of $10 million — under 10% of corporate revenue, but growing at a rate that makes the next two halves legible. The caveat management volunteers is the right one: corporate migration only finished in Q4 FY26, so commercial and marketing effort against this base is barely a year old.

The sentence that changes the story

Everything above is a plausible turnaround narrative that has been in the works for several quarters — multiproduct adoption was already a top-five theme two quarters ago. The new fact in this report is buried in the opening paragraph and again in the final Q&A.

Discussions with Equals continue on a nonexclusive basis. The Board is very engaged. The opportunity is still being assessed and both parties continue to apply resources to reach a conclusion.

John Malcolm, CEO · 2026-11-09
Exclusivity has lapsed. And when asked whether the other interested parties from before the exclusive period had been re-approached, the CEO gave the shortest answer of the call: “I mean, obviously, it's very sensitive. So there's only so much I can say, but I guess the short answer is yes.” — John Malcolm, CEO · 2026-11-09 That is a material shift from the May update, when the language was static reassurance: “There are still multiple credible parties that we're working with.” — John Malcolm, CEO and Managing Director · 2026-05-18 An strategic review that began as a process with many suitors, narrowed to one exclusive counterparty, has now re-opened. Investors are being asked to price both a turnaround and an option.

What management stopped talking about

The most striking absence in this call is not a keyword but a voice. Twelve months ago the Q&A was dominated by a furious retail shareholder who laid out the damage in detail: a $130 million market capitalisation, an enterprise value of roughly $100 million, a share price that had gone from $2.30 to $0.57, "$400 million" of value destroyed in fourteen months, and the accusation of Russian Roulette with the OpEx of the platform rebuild. He asked directly whether the Board was considering a sale. The answer then was flat denial: “And the answer to the third question is no, we're not actively engaged or strategic on a sale of the [indiscernible].” — John Malcolm, CEO and Managing Director · 2025-11-10 A year later there is a live process with Equals and other parties, and that questioner is simply gone from the queue. This call drew one analyst, one question set, three follow-ups. The market cap referenced in the metadata here is $72 million — lower than the figure the aggrieved shareholder was using as evidence of failure. What has *not* gone away is the operational mess that has repeatedly embarrassed the guidance. Bad debts of $3.8 million for the half, of which the CFO attributes the driver plainly: “The main driver of these continue to be the direct debit fraud -- continue to be direct debit fraud in North America.” — James Georgeson, CFO · 2026-11-09 That is a direct debit fraud problem flagged a year ago, again in the interim, and still being managed with "additional controls" rather than eliminated. Guidance has also been rebuilt downward more than once: the prior chief financial officer spoke of an OpEx range of a $16–24 million bonus swing; the current guide is a $159–162 million full-year base with short-term incentives to be funded at 100% only in FY28.

The verdict

OFX is now a very small company telling a very specific story: the three-year, $57 million platform build and corporate client migration are finished, the cost line is reset, engagement economics on multiproduct clients are demonstrably better, and the second half should show it. That story is testable within two quarters and is coupled to an open-ended sale process that management cannot discuss. The risk is equally specific: FY28 guidance of "modest" NOI growth with a slightly lower cost base assumes no improvement in business confidence and no recurrence of the fraud losses — in other words, it assumes the operating environment stays exactly as bad as it is now, and only the company's own execution improves. For a stock whose enterprise value has already been stripped to roughly its cash and platform, that is a defensible bet. It is not yet a proven one.